Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy

Omada Health (NASDAQ:OMDA) highlighted grounds second-quarter gross and borderline show astatine the Canaccord Genuity Growth Conference, portion outlining its strategy to grow crossed cardiometabolic conditions, deepen transmission partnerships and usage GLP-1-related request to broaden lawsuit relationships.

Steve Cook, Omada's CFO, said the institution was founded successful 2010 with the extremity of addressing cardiometabolic disease. The institution began with its Prevention & Weight Health offering earlier entering diabetes and hypertension successful the 2018-2019 period. Omada aboriginal expanded into musculoskeletal attraction done its 2020 Physera acquisition and has much precocious introduced cholesterin and GLP-1-related offerings.

→ SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat

Cook said Omada present serves 1.1 cardinal members and works with each 3 large pharmacy payment managers, arsenic good arsenic aggregate ample wellness plans. He cited Costco arsenic an illustration of a long-standing lawsuit that has adopted Omada's further products implicit time.

Leadership modulation and quarterly show

Cook discussed a enactment alteration announced the anterior week. Co-founder and CEO Sean volition modulation to enforcement chairman, portion President Wei Shao volition go CEO. Cook said Shao has been with Omada for astir 7 years, became president 4 years agone and antecedently spent much than 2 decades astatine Eli Lilly and Company.

→ Quantum Earnings Week: Winners and Losers Are Finally Emerging

Sean volition stay actively progressive with the business, focusing connected outer relationships with wellness plans and different stakeholders, according to Cook.

For the 2nd quarter, Cook said Omada reported grounds gross of $88 million, up 43% twelvemonth implicit year. The institution besides reported a grounds gross borderline of 74% and adjusted EBITDA of $10.8 million.

→ Take-Two's Q1 Results Leave GTA 6 Bulls Stuck successful the Fog of War

Cook said maturation was broad-based crossed Omada's merchandise portfolio, with diabetes and hypertension among the company's fastest-growing offerings. Those products transportation higher pricing and stronger beingness value, helium said.

"The GLP-1 speech is acting arsenic a extremity of the spear, and past we tin spell and cross-sell crossed our full merchandise suite," Cook said.

Engagement-based concern exemplary and seasonality

Omada's gross exemplary is tied to subordinate engagement alternatively than a accepted per-employee-per-month structure, Cook said. The institution charges erstwhile members actively usage its programs done activities specified arsenic communicating with a coach, utilizing connected devices oregon participating successful a community.